O
Ovid Therapeutics Inc. (OVID)
2.30
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
2.30
0.00 (0.00%)
This stock has a consensus price target of $4.20 based on the ratings of 11 analysts. The high is $7.00 and the low is $1.20.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 1.2 | $ 4.2 | $ 7 |
| O’zgarish | -47.83% | 82.61% | 204.35% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-26 | 73.91% | BTIG | $4 → $4 | Reiterates | Buy |
| 2026-03-20 | 204.35% | Wedbush | $5 → $7 | Maintains | Outperform |
| 2025-12-22 | 73.91% | LifeSci Capital | $4 | Initiates Coverage On | Outperform |
| 2025-12-22 | -13.04% | HC Wainwright & Co. | $2 → $2 | Reiterates | Buy |
| 2025-12-11 | 30.43% | Roth Capital | $3 | Initiates Coverage On | Buy |